🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
The purpose of this study is to complement Study CBYL719C2301 (SOLAR-1) and...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2021-12-17
Trial ID
NCT05038735
Treatments Being Tested
The purpose of this study is to evaluate efficacy and safety of CDK4/6 inhi...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2019-09-13
Trial ID
NCT04526028
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of a new dose of 500m...
Status
Completed
Location
Research Site
Start Date
2011-03
Trial ID
NCT01300351
Treatments Being Tested
A assessment of the efficacy of first-/second-line endocrine therapies ± ta...
Status
Unknown
Location
N.N. Blokhin National Medical Research Center of Oncology
Start Date
2021-01-01
Trial ID
NCT04852081
Treatments Being Tested
This study was designed to assess the safety and efficacy of the combinatio...
Status
Terminated
Location
Washington Uni School of Med Siteman Cancer Center
Start Date
2022-04-06
Trial ID
NCT04899349
Treatments Being Tested
This is a Phase 1, open-label, multicenter, dose escalation and dose expans...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-15
Trial ID
NCT05905341
The purpose of this study was to find out how effective the combination of ...
Status
Completed
Location
Beatson West of Scotland Cancer Centre
Start Date
2019-05-09
Trial ID
NCT03620643
This is a multicenter, prospective, randomized, open-label, controlled phas...
Status
Completed
Location
Studienzentrum Onkologie Ravensburg
Start Date
2018-03-15
Trial ID
NCT03555877
Treatments Being Tested